ECA
AMGN icon

Elevated Capital Advisors’s Amgen AMGN Stock Holding History

Elevated Capital Advisors’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.04M Buy
2,960
+1,761
+147% +$628K 0.26% 93
2025
Q4 		$392K Sell
1,199
-208
-15% -$66K 0.09% 217
2025
Q3 		$397K Sell
1,407
-164
-10% -$47.6K 0.1% 218
2025
Q2 		$489K Hold
1,571
– – 0.14% 192
2025
Q1 		$489K Sell
1,571
-93
-6% -$27.5K 0.14% 192
2024
Q4 		$434K Buy
1,664
+125
+8% +$37.1K 0.12% 205
2024
Q3 		$496K Buy
1,539
+38
+3% +$12.4K 0.13% 202
2024
Q2 		$469K Buy
1,501
+173
+13% +$50.8K 0.13% 179
2024
Q1 		$378K Buy
1,328
+98
+8% +$28.7K 0.11% 148
2023
Q4 		$354K Buy
1,230
+114
+10% +$31.1K 0.11% 148
2023
Q3 		$300K Sell
1,116
-20
-2% -$4.99K 0.1% 151
2023
Q2 		$252K Buy
1,136
+134
+13% +$31.1K 0.08% 166
2023
Q1 		$242K Buy
1,002
+56
+6% +$13.7K 0.09% 160
2022
Q4 		$248K Buy
+946
New +$254K 0.09% 146
2019
Q4 		$251K Buy
+1,041
New +$229K 0.28% 98
2019
Q1 		$576K Buy
+2,598
New +$496K 0.38% 95

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Elevated Capital Advisors's AMGN Position: Q1 2026 in Review

Elevated Capital Advisors increased its Amgen (AMGN) stake by 147% in Q1 2026, buying an estimated $628K and bringing the position to 2,960 shares worth $1.04M. The position accounts for 0.26% of the portfolio, ranked #93.

Elevated Capital Advisors first reported a position in AMGN in Q1 2019 and has held it in 16 quarters since. 3,131 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • Elevated Capital Advisors held 2,960 shares of Amgen worth $1.04M as of Q1 2026.
  • Elevated Capital Advisors bought 1,761 Amgen shares in Q1 2026, an estimated $628K.
  • Amgen made up 0.26% of Elevated Capital Advisors's portfolio in Q1 2026, its #93 holding.
  • Elevated Capital Advisors first reported a position in Amgen in Q1 2019 and has held it in 16 quarters since.
  • 3,131 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on Elevated Capital Advisors's 13F filing for Q1 2026, filed 30 Apr 2026.